Linden Announces Closing of New $375 Million Investment Fund

Oversubscribed Offering for Linden's Second Healthcare Focused Fund Surpasses Target of $300 Million

Jun 25, 2010, 09:30 ET from Linden LLC

CHICAGO, June 25 /PRNewswire/ -- Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II ("LCP II"), which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million.

Linden's second fund continues the strategy from its first fund, executed through industry specialization in healthcare and life science, a focus on building and maintaining corporate relationships, and integrating Operating Partners in investment decisions and management.  Linden received strong support from its institutional investors, 100% of whom reinvested in LCP II.  In addition, the firm attracted new global LPs, state pension plans, foundations, funds of funds, and family offices.

Linden Founder and Partner, Eric Larson, said, "We are pleased to have exceeded our fundraising target in a very demanding environment.  This was definitely a team effort, involving the entire Linden organization as well as the talented managers at our portfolio companies."  Brian Miller, Linden Founder and Partner, continued, "It is the consistent ability of our portfolio companies' executive teams to improve the performance of the companies we own that continues to reward our investors and attract new ones, and we thank them for their important role in this successful outcome."

Linden Founder and Partner, Tony Davis, said, "We have worked very hard to deliver returns to our investors, and we are extremely pleased to have surpassed our fundraising expectations with strong support from our existing limited partners.  We also want to welcome our highly regarded new group of investors to our global investor base.  With their collective support, Linden looks forward to the continuous improvement of our approach to creating value in the companies we acquire."

Linden this year was named as Best New Firm by Buyouts magazine, which cited "impressive" exits and the firm's pursuit of "small healthcare companies that are poised to benefit from market trends."

LCP II follows Linden's successful first fund of $200 million, established in 2006.  Park Hill Group served as placement agent for LCP II, and Kirkland & Ellis served as legal counsel.

About Linden Capital Partners

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries.  Linden's strategy is based upon four elements: i) specialization on middle market healthcare and life science companies, ii) integrated private equity and operating expertise, iii) customized value creation programs for each portfolio company, and iv) strategic relationships with large corporations.  Linden's portfolio includes BarrierSafe Solutions International, Behavioral Centers of America, CORPAK MedSystems, Drayer Physical Therapy, Focused Health Solutions, Hycor Biomedical, and Ranir.  For additional information, please visit


Chris Tofalli